FDA Inspection 759123 — Bloodworks

Bloodworks — FEI 3009058002

The FDA completed an inspection of Bloodworks on Dec 6, 2011 in Seattle, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 6, 2011
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Seattle, WA (United States)

Citations

IDCFRDescription
16021 CFR 606.160(a)(1)Person performing, test results, interpretation
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.